Tenet Healthcare Corporation

THCServices-General Medical & Surgical Hospitals, NECNYSE
Revenue (FY2025)$21.31B
Net margin6.6%
Revenue growth+3.1%
Dividend / shareNone
Held by ETFs125
1 week-0.2%
1 month+4.1%
3 months+2.2%
6 months+51.3%
YTD+35.1%
1 year+31.2%
3 years*+71.6%

Total returns with dividends reinvested; * a year. Prices as of Oct 28, 2026 · filings through Sep 30, 2026 · page updated Nov 3, 2026

At a glance

Tenet Healthcare Corporation is worth $21.37B, about 17 times its fiscal 2025 earnings. Revenue grew 3.1% to $21.31B in fiscal 2025, with 6.6% kept as profit; over 5 years it has grown 3.9% a year. It pays no dividend; it spent $2.51B buying back its shares over FY2021–FY2025. The stock returned +31.2% over the past year with dividends reinvested, against +11.5% for the S&P 500.

The business in plain English

Tenet Healthcare, based in Dallas, Texas, runs hospitals, outpatient surgery centers and a billing services business. Health plans and government programs pay for most of the care it provides. In fiscal 2025, about 70% of net patient service revenue at its hospitals and related outpatient sites came from managed care payers. These are health plans that negotiate set rates with providers, including Medicare and Medicaid managed care plans.

Hospital Operations and Services brought in $16.1 billion in fiscal 2025, about 76% of total revenue of $21.3 billion. At December 31, 2025, it had 50 hospitals with 12,494 licensed beds in eight states. It also had 132 outpatient sites such as urgent care and imaging centers, and about 74% of them were in Arizona and Texas. The segment also includes Conifer Health Solutions, which handles insurance checks, coding, billing and collections for about 600 hospitals and other clients. Tenet returned to full ownership of Conifer effective January 1, 2026.

Ambulatory Care, run by the subsidiary USPI, produced $5.2 billion, about 24% of revenue. USPI held stakes in 533 ambulatory surgery centers, where patients usually go home the same day, and 26 surgical hospitals in 37 states. It builds and acquires these sites mainly through joint ventures with physicians and health systems. Common procedures include orthopedic and joint replacement surgery, digestive tract procedures, pain management, eye surgery and urology.

Price history

The interactive chart needs JavaScript.

THC +31.2% over the year to Oct 28, 2026, total return with dividends reinvested.

Prices through Oct 28, 2026. Total return: the price with dividends reinvested.

How it makes money

By business segment

Hospital Operations$16.14B75.7%
Ambulatory Care$5.17B24.3%
Fiscal year ended Dec 31, 2025, from the 10-K's XBRL data; shares of total revenue ($21.31B).

Latest results

  • In Q3 FY2026 (ended Sep 30, 2026), revenue was $5.63B, up 6.5% from a year earlier, and net income was $1.00B (+192.4%).
  • For fiscal 2025, revenue was $21.31B (+3.1% year over year; +3.9% a year from FY2020 to FY2025) with a 6.6% net margin.

Financial health check

Revenue growth a year (FY2020–FY2025)+3.9% watch
Operating margin16.5% good
Free cash flow margin11.9% good
Return on equity (FY2025)33.3% good
Return on assets (FY2025)4.7% watch
Net cash (cash minus debt)$-10.57B weak
Fiscal yearRevenueNet incomeFree cash flow
FY2020$17.64B$399.0M$2.87B
FY2021$19.48B$914.0M$910.0M
FY2022$19.17B$411.0M$321.0M
FY2023$20.56B$611.0M$1.62B
FY2024$20.68B$3.20B$1.12B
FY2025$21.31B$1.41B$2.53B

Cash returned to shareholders

  • Over FY2021–FY2025: $2.51B in buybacks and $0.00 in dividends.
  • The company pays no regular dividend.
  • Shares outstanding changed -25.9% from Jan 31, 2022 to Oct 23, 2026.

Valuation snapshot

Market value$21.37B
P/E ratio17.3
Dividend yieldNone
As of Oct 28, 2026.

Rank among 1514 US companies

Market value at each year end

End of 2022: $5.28B$5.3B2022End of 2023: $7.67B$7.7B2023End of 2024: $12.00B$12.0B2024End of 2025: $17.46B$17.5B2025Oct 28, 2026: $21.37B$21.4BNow
End of 2022: $5.28B$5.3B2022End of 2023: $7.67B$7.7B2023End of 2024: $12.00B$12.0B2024End of 2025: $17.46B$17.5B2025Oct 28, 2026: $21.37B$21.4BNow

Tenet Healthcare’s market value went from $5.28B at the end of 2022 to $21.37B on Oct 28, 2026, about 4.1 times as much; since the end of 2025 it is up 22%.

Show as a table
Year endMarket valueChange
Oct 28, 2026$21.37B+22.4%
2025$17.46B+45.5%
2024$12.00B+56.4%
2023$7.67B+45.5%
2022$5.28B
The year-end close times the shares outstanding on the latest 10-K or 10-Q cover before it. Changes in market value include new shares issued and shares bought back, so they differ from the stock’s return.

Price behavior

Volatility (1 year)42.5%annualized; the S&P 500 is usually 15–20%
Worst drop (1 year)-34.1%3 years: -34.5% · all history: -36.9%
Beta vs S&P 5000.43moves less than the market
Sharpe ratio (1 year)0.64return above cash per unit of risk
Since price data starts+46.7%a year over 4.1 years
52-week range$161.37 – $280.77
Last price $268.50 on Oct 28, 2026, 4.4% below the 52-week high · above its 200-day average ($219.93).
YTD1 yr3 yr5 yr10 yr
THC price data to Oct 28, 2026+35.1%+31.2%+71.6%——
Multi-year figures are annualized total returns with dividends reinvested, computed from daily prices.
55%202367%202457%202535%2026*
55%202367%202457%202535%2026*
Calendar-year total returns from price data, dividends reinvested. * 2026 is year to date.
Show as a table
YearPrice data
2026 (to date)+35.1%
2025+57.4%
2024+67.0%
2023+54.9%
2008 financial crisis
stocks fell Oct 9, 2007 – Mar 9, 2009
Before this security existed
2020 COVID crash
stocks fell Feb 19, 2020 – Mar 23, 2020
Before this security existed
2022 bear market
stocks fell Jan 3, 2022 – Oct 12, 2022
Before this security existed

Insider activity

Form 4 filings from 2025-10-30 to 2026-10-30 (25 read): 0 open-market purchases and 25 sales ($51.5M).

DateInsiderTypeValue
Aug 24, 2026Saumya Sutaria CEO, Directorsell$10.2M
Aug 25, 2026Saumya Sutaria CEO, Directorsell$6.8M
Aug 31, 2026Lisa Y Foo EVP, Chief Operating Officersell$6.4M
Aug 25, 2026Saumya Sutaria CEO, Directorsell$4.7M
Aug 24, 2026Saumya Sutaria CEO, Directorsell$3.7M

Who owns it

Large shareholders (13G filings)

BlackRock, Inc.10%Aug 31, 2026
T. Rowe Price Associates, Inc.9.2%Jun 30, 2026
Vanguard Capital Management5.26%Mar 31, 2026
FMR LLC4.6%Jun 30, 2026
Invesco Ltd.4.4%Mar 31, 2025

ETFs with the most weight in THC

TXS Texas Capital Texas Equity Index ETF5.17%
FXH First Trust Health Care AlphaDEX Fund2.25%
XMHQ Invesco S&P MidCap Quality ETF2.25%
SMRI Bushido Capital US Equity ETF2.09%
QVAL Alpha Architect U.S. Quantitative Value ETF2.06%
XHS SPDR S&P Health Care Services ETF2.04%
SMDX Intech S&P Small-Mid Cap Diversified Alpha ETF1.86%
IHF iShares U.S. Healthcare Providers ETF1.79%
Held by 125 ETFs in our database.

What could go wrong

  1. Heavy reliance on a few health plans. About 70% of fiscal 2025 hospital patient revenue came from managed care payers, and the top 10 supplied 69% of that. Lower rates, payment denials or a lost contract could hurt results.
  2. Concentrated in a few states. Its 50 hospitals were in eight states at the end of 2025, and about 74% of its hospital-segment outpatient centers were in Arizona and Texas. Local downturns, disasters or rule changes there could hurt results.
  3. A large debt load. Total debt was about $13.2 billion as of June 30, 2026, against $2.2 billion of cash and investments. Heavy debt can limit flexibility in a downturn, and lender rules called covenants restrict some actions.
  4. Dependence on doctors and joint venture partners. USPI builds and acquires surgery centers mainly through joint ventures with physicians and health systems. Losing key partners or failing to attract needed specialists could reduce patient volumes and slow growth.
  5. Health policy changes could shrink paying patients. Some expanded Affordable Care Act provisions expired at the end of 2025, and Tenet expects more uninsured people from 2026. Changes or cuts to Medicare and Medicaid could also hurt results.
  6. Rising labor costs and staff shortages. Competition for staff, a shortage of experienced nurses and other health workers, and union activity have raised Tenet's labor costs. The company warns this may continue.

Recent events

  • Quarterly results released
  • Major agreement signed; New debt or financial obligation
  • Investor presentation or announcement; Other company announcement
  • Quarterly results released
  • Shareholder vote results
  • Quarterly results released
  • Executive or board change
  • Executive or board change
  • Quarterly results released
  • Quarterly results released; Investor presentation or announcement; Other company announcement

For income and retirement investors

Tenet paid no dividends from fiscal 2021 through fiscal 2025 and had no dividend yield as of October 28, 2026. That means the stock offers no regular income, and an income investor would need to sell shares to raise cash. Tenet returns cash through buybacks instead. These totaled about $2.5 billion over those five years, including $1.39 billion in fiscal 2025. The share count fell about 25%, from roughly 107.1 million in October 2021 to 80.5 million in July 2026, so each remaining share gets a bigger slice of profits.

Our price record for Tenet covers about 4.1 years to October 28, 2026. It does not cover the 2008 financial crisis, the 2020 COVID crash or the 2022 bear market. Within that record, the deepest drop from a peak was about 37%. The shares also fell about 34% at one point in the year to that date. Single stocks carry more risk than diversified funds.

Questions investors ask

How does Tenet Healthcare make money?

Mostly by treating patients and collecting from health plans and government programs. In fiscal 2025, its Hospital Operations segment produced about 76% of $21.3 billion in revenue. At year-end it had 50 hospitals and 132 outpatient sites. That segment also includes Conifer Health Solutions, which handles billing, coding and collections for about 600 hospitals and other clients. Ambulatory Care, run by USPI, produced about 24%. USPI held stakes in 533 surgery centers and 26 surgical hospitals.

Does Tenet Healthcare pay a dividend?

No. Tenet paid no dividends from fiscal 2021 through fiscal 2025 and had no dividend yield as of October 28, 2026. It returns cash to shareholders through stock buybacks instead. It spent about $2.5 billion on buybacks over those five years, including $1.39 billion in fiscal 2025. That helped cut the share count by about 25% between October 2021 and July 2026. Investors who need regular income would get none directly from this stock.

How has Tenet Healthcare stock performed?

It has risen sharply, with big swings. As of October 28, 2026, the share price was up about 31% over one year and about 405% over three years, or roughly 72% a year. The price rose about 55% in 2023, 67% in 2024 and 57% in 2025. In 2026 it was up about 35% year to date. The stock also fell about 34% from a peak at one point in the year to that date. Past gains may not repeat.

How much debt does Tenet Healthcare have?

About $13.2 billion in total debt as of June 30, 2026. It had about $2.2 billion of cash and investments, which left net debt of about $11.1 billion. Shareholders' equity was about $4.7 billion. Tenet's 10-K annual report warns that this debt could limit its ability to raise capital and respond to downturns. Rules set by lenders, called covenants, also restrict some of its actions. A filing dated September 22, 2026 reported a major agreement and a new debt obligation.

Which ETFs hold Tenet Healthcare stock?

Tenet appears in about 125 ETFs. The funds that give it the most weight include Texas Capital Texas Equity Index ETF (TXS) at about 5.2%. First Trust Health Care AlphaDEX Fund (FXH) and Invesco S&P MidCap Quality ETF (XMHQ) hold about 2.3% each. SPDR S&P Health Care Services ETF (XHS) holds about 2.0% and iShares U.S. Healthcare Providers ETF (IHF) about 1.8%. Fund weights change over time. A fund spreads risk across many companies rather than relying on one hospital operator.

Sources

  • SEC company facts (XBRL financial data), filed Oct 29, 2026 — SEC EDGAR
  • 10-K annual report, filed Feb 17, 2026 — SEC EDGAR
  • Prices: daily prices and dividends through Oct 28, 2026

For education only, not investment advice. Past performance does not predict future results.